GCCA
10.5.2022 01:03:12 CEST | Business Wire | Press release
The Global Cement and Concrete Association (GCCA) has today revealed the first six start-ups that will be backed by its member companies as part of the first ever Innovandi ‘Open Challenge’ in the race to ‘net zero’ by 2050.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220509005690/en/
The six start-ups, which were chosen from more than 100 entrants to the Open Challenge, hail from the USA, Canada, UK, Italy and the Netherlands. They have now joined forces with world-leading cement companies to help drive further innovation in the industry and will each form part of formal consortia to further test, develop and deploy their ground-breaking technologies.
One of the key focuses of the industry is to develop the technology and implementation for carbon capture, utilisation and storage (CCUS), with CarbonOrO, MOF Technologies and Saipem among the start-ups that the industry is backing. GCCA members have committed to moving from the dozens of pilot projects and announcement already underway to having 10 industrial scale carbon capture plants by 2030 as part of the landmark Net Zero Roadmap, announced in October 2021. CCUS includes a range of technologies and methods that “capture” CO2 from large sources – such as in industrial power generation. The CO2 is then either used on site or compressed and transported to be used or stored elsewhere.
Carbon Upcycling Technologies and Fortera both use captured CO2 to produce low-carbon cement and cementitious materials. The other confirmed start-up is Coomtech, a British business that has developed a low-cost drying technology using kinetic energy created by managed, turbulent air.
Six newly established consortia will help to accelerate the development of technologies that reduce or eliminate carbon throughout the cement and concrete value chain. Each consortium is made up of a start-up company, with their respective pioneering technology, and includes between three and eight cement companies, with 16 GCCA member companies involved across the six innovation consortia.
Thomas Guillot, GCCA Chief Executive , said: “It’s a proud moment to see the industry coming together to support such innovative start-ups on their journey. Our member companies were greatly impressed by their ambition to be a key part of the climate solution. The programme is another big step forward towards unlocking innovation to help us achieve our net zero goal.
“As the need for resilient and sustainable communities to support a growing global population becomes more pressing, cement and concrete will be essential to providing the infrastructure and buildings that society needs. Achieving net zero concrete relies on a number of different groups playing their part, and as an industry we’re looking outwards as well as inwards, to see how start-ups like these can support our goals.
"To achieve net zero globally by 2050, we also need to involve and support the future generations who contribute innovative ideas and energy to the industry. At GCCA, we’re identifying and convening research and development with great potential and offering our support through guidance and effective collaboration.”
These young start-ups are the future generation to help accelerate the industry’s progress, and as an accelerator of the United Nations (UN) Race to Zero campaign, GCCA continues to support innovative development to achieve net zero concrete globally.
The members of each consortia are working together to develop their technologies ahead of a demonstration day, scheduled for late 2022. GCCA worked with Techstars, the worldwide network that helps entrepreneurs succeed, to identify start-ups for the challenge. To find out more about the Innovandi programme please visit https://gccassociation.org/innovandi/ .
ENDS
About the Innovandi Open Challenge
Launched in 2021 the Open Challenge is a key part of the industry’s commitment to achieve net zero. This first-ever edition provides the platform for start-ups to drive innovation in the cement and concrete sectors. The Open Challenge focuses on developing carbon capture and calcination technologies, as well as improving carbon use in the construction supply chain and the recycling process of concrete. By partnering with the start-ups, member companies will provide them with their global resources and the support they need to grow and refine their product.
Shortlisted start-ups that have not yet formed formal consortia are being mentored by GCCA to help develop their technologies. Further consortia are expected to be announced in the course of the next weeks.
In addition to the formal consortia, the Open Challenge has led to two GCCA members (Cementos Argos and Holcim) supporting Minus Materials as industrial partners in the US Department of Energy ARPA-E grant for $3 million.
The six shortlisted start-ups are:
-
CarbonOrO
(The Netherlands)
- Carbon capture technology using unique bi-phasic amine with a lower cost of capture.
- Supported by CEMEX, Holcim, SCG, Titan Cement, UltraTech Cement and Votorantim Cimentos.
-
Carbon Upcycling Technologies
(Canada)
- Using a patented, low-energy process, Carbon Upcycling Technologies chemically activates and captures CO2 within solid waste materials to produce a range of supplementary cementitious materials, to create low carbon cement and concrete.
- Supported by Cementos Argos, CEMEX, CRH, Holcim, Shree Cement and Taiheiyo.
-
Coomtech
(UK)
- Coomtech has developed a low energy, low cost drying technology using managed turbulent air, creating kinetic energy to remove moisture.
- revolutionising a 100-year-old process, a single Coomtech-enabled plant can cut CO2 emissions by the equivalent of more than 600,000 mature trees per year and is 75% cheaper to operate.
- Supported by Buzzi Unicem, CRH, JSW Cement and UltraTech Cement.
-
Fortera
(USA)
- Fortera’s technology captures CO2 emissions from cement plants, combining it with calcium to make reactive calcium carbonate. It is stable in dry powder form and its cementitious properties are activated when wetted.
- Supported by Cementos Argos, CRH, Holcim, JSW Cement, Taiheiyo Cement and Ultratech Cement.
-
MOF
Technologies
(UK)
- Nuada carbon capture technology uses Metal-Organic Frameworks (MOFs) to deliver energy-efficient CO2 removal at a fraction of the cost of conventional amines
- Supported by Buzzi Unicem, Cementir Holding and HeidelbergCement,
-
SAIPEM
(Italy)
- Saipem has developed a revolutionary carbon capture technology using a non-volatile aqueous carbonate solution catalysed by enzymes that neither require nor produce toxic products. The process can capture post-combustion emissions directly from industrial sources, like chimneys, using low-grade residual heat to drive the process.
- Supported by Buzzi Unicem, Cementir Holding, Cementos Molins, CEMEX, GCC, Holcim, Titan Cement and Votorantim Cimentos.
Supporting quotes
Start-ups
Jan Hoppenbrouwers, Co-Owner and Head of Sales & Marketing, CarbonOrO
“There is a lot of talk about CCUS, but worldwide, there is only a limited number of active test projects lined up so far. With so little time left, this makes you wonder. GCCA members and their consortia’s joined efforts have all the characteristics to change this. Thank you for that.”
Natalie Giglio, Senior Business Development Associate, Carbon Upcycling Technologies
“At Carbon Upcycling, we've created a novel technology that uses CO2
as a resource rather than a waste for the cement industry. By using abundant, local waste materials and CO2
directly from cement kilns, we enable circularity within local supply chains. Participating in the Innovandi Open Challenge has given us a platform to take our ready-to-deploy technology and accelerate its pathway to global commercialisation."
Chris Every, Chief Commercial Officer & Founder, Coomtech
“As a young business seeking to establish a radical new technology there is usually no short cut to the industries you are targeting or clients you seek to inform and demonstrate capability to. Each prospect must be individually developed and nurtured. The Innovandi Open Challenge combines a stringent review process with access to the combined power of the biggest global players in the cementitious market. The Challenge provides those of us who have succeeded in clearing the evaluation hurdles along the way, a unique and hugely valuable direct access to our prospective markets and technology users. We are delighted and proud to have been selected as a consortium partner in the Innovandi Open Challenge and are excited to begin the execution stage, delivering Coomtech’s contribution to a cleaner and more cost-effective cement industry.”
Ryan Gilliam, CEO, Fortera
“We’re very pleased that our technology has been chosen by the Innovandi Open Challenge for industry collaboration. Fortera has developed a process for manufacturing cost-competitive, low-carbon cement at a time when net-zero solutions are urgently needed. We look forward to our collaboration with GCCA partners in furthering climate-friendly alternatives that deliver the cost and performance of Portland cement while sequestering carbon within the built environment.”
Dr. Conor Hamil, Co-CEO, MOF Technologies
“Having developed a carbon capture system that overcomes the traditional adoption barriers of energy and cost, we are thrilled to be working with members of the GCCA to bring our technology to the field. Our Nuada carbon capture technology has been designed to deliver the ultra-efficient CO2
separation needed to overcome these barriers, enabling our partners to reach their net zero targets. We are therefore thrilled to be participating in the Innovandi Open Challenge and playing our part in decarbonising the concrete value chain.”
Saipem
“Saipem is proud to attract GCCA members’ interest in its unique enzymatic carbon capture technology. GCCA’s open innovation program positively contributes to accelerating the adoption of carbon capture technologies. SAIPEM will work with GCCA consortium members to improve from traditional carbon capture technologies’ environmental and energy footprint, helping the cement sector decarbonize its operations competitively while positively impacting many other hard-to-abate industrial sectors. This recognition further confirms Saipem’s leading role in the CCUS sector, where Saipem has the competencies, skills, assets and technologies to serve the entire value chain.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005690/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 13:00:00 CEST | Press release
Milestones advance clinical progress and path to commercialization CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which w
Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 13:00:00 CEST | Press release
Poster presentations highlight the prognostic value of MammaPrint + Blueprint in small, node-negative tumors and impact of BMI on recurrence dynamics Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors –
The Biggest Predictor of Business Growth Is Behavior30.4.2026 09:00:00 CEST | Press release
New IDEO research reveals a gap in the behaviors that most drive growth: long-term vision, rapid experimentation, and team autonomy—with only 10% of leaders saying their company excels at the combination. IDEO, the global design and innovation company, today announced the IDEO Innovation Quotient (IDEO IQ), a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. Those with the highest IDEO IQ scores earned nearly $20 billion in profit last year—50% higher than average and three times more than those ranked at the bottom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429978890/en/ The IDEO Innovation Quotient (IDEO IQ) is a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. The IDEO IQ surveyed 266 leaders in product and innovation roles at 100 of the world’s largest companies across the Media &
Suzano Sells 12.7 Million Tonnes of Pulp for the First Time in Its History30.4.2026 00:22:00 CEST | Press release
Suzano(B3: SUZB3 | NYSE: SUZ), the world’s largest pulp producer, announces its results for the first quarter of 2026 (1Q26), achieving a new all‑time record in pulp sales. Over the 12‑month period from April 2025 to March 2026, the company sold 12.7 million tonnes of pulp, the highest volume ever recorded in its history. During the same period, Suzano also sold 1.7 million tonnes of paper across the packaging, printing and writing, specialty, and tissue segments. This unprecedented sales level mainly reflects the increase in production capacity following the start‑up of the Ribas do Rio Pardo pulp mill in the state of Mato Grosso do Sul, as well as Suzano’s strong operational efficiency across its production lines and supply chains, serving customers in more than 100 countries worldwide. In the first quarter of 2026, Suzano sold a total of 3.2 million tonnes, comprising 2.8 million tonnes of pulp and 378 thousand tonnes of paper. Net revenue amounted to BRL 11.0 billion, while adjuste
The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN29.4.2026 22:30:00 CEST | Press release
Surgeon-Founded Brand Anchored by Innovative NAC Y2™ Technology The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429495879/en/ 111SKIN's Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. Building on the foundation of this clinical expertise, 111SKIN has developed a portfolio of more than 30 products, anchored by its Black Diamond and Reparative collections and priced from $50 to $1,000. “Skin care is entering a new
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
